Quinacrine mustard

Identification

Generic Name
Quinacrine mustard
DrugBank Accession Number
DB02240
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 468.85
Monoisotopic: 467.1297956
Chemical Formula
C23H28Cl3N3O
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UTrypanothione reductase
inhibitor
Trypanosoma cruzi
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Product Ingredients
IngredientUNIICASInChI Key
Quinacrine mustard dihydrochlorideRCB69HPY0X4213-45-0JETDZFFCRPFPDH-GGMCWBHBSA-N

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as acridines. These are organic compounds containing the acridine moiety, a linear tricyclic heterocycle which consists of two benzene rings joined by a pyridine ring.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Quinolines and derivatives
Sub Class
Benzoquinolines
Direct Parent
Acridines
Alternative Parents
Chloroquinolines / Nitrogen mustard compounds / Anisoles / Alkyl aryl ethers / Pyridines and derivatives / Aryl chlorides / Secondary ketimines / Heteroaromatic compounds / Trialkylamines / Azacyclic compounds
show 4 more
Substituents
Acridine / Alkyl aryl ether / Alkyl chloride / Alkyl halide / Amine / Anisole / Aromatic heteropolycyclic compound / Aryl chloride / Aryl halide / Azacycle
show 18 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
aminoacridines, nitrogen mustard (CHEBI:37595)
Affected organisms
Not Available

Chemical Identifiers

UNII
8Y3YQP8GW6
CAS number
64046-79-3
InChI Key
UKOBAUFLOGFCMV-UHFFFAOYSA-N
InChI
InChI=1S/C23H28Cl3N3O/c1-16(4-3-11-29(12-9-24)13-10-25)27-23-19-7-5-17(26)14-22(19)28-21-8-6-18(30-2)15-20(21)23/h5-8,14-16H,3-4,9-13H2,1-2H3,(H,27,28)
IUPAC Name
N-{5-[bis(2-chloroethyl)amino]pentan-2-yl}-6-chloro-2-methoxyacridin-9-amine
SMILES
COC1=CC2=C(NC(C)CCCN(CCCl)CCCl)C3=CC=C(Cl)C=C3N=C2C=C1

References

General References
Not Available
PubChem Compound
20194
PubChem Substance
46507946
ChemSpider
19021
ChEBI
37595
ChEMBL
CHEMBL1190232
PDBe Ligand
QUM

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.000967 mg/mLALOGPS
logP6.74ALOGPS
logP5.77Chemaxon
logS-5.7ALOGPS
pKa (Strongest Basic)8.38Chemaxon
Physiological Charge2Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area37.39 Å2Chemaxon
Rotatable Bond Count11Chemaxon
Refractivity128.15 m3·mol-1Chemaxon
Polarizability50.91 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability0Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.974
Blood Brain Barrier+0.9449
Caco-2 permeable+0.5625
P-glycoprotein substrateSubstrate0.7776
P-glycoprotein inhibitor IInhibitor0.6048
P-glycoprotein inhibitor IIInhibitor0.9484
Renal organic cation transporterInhibitor0.8752
CYP450 2C9 substrateNon-substrate0.8106
CYP450 2D6 substrateNon-substrate0.6715
CYP450 3A4 substrateSubstrate0.6881
CYP450 1A2 substrateInhibitor0.7579
CYP450 2C9 inhibitorNon-inhibitor0.8644
CYP450 2D6 inhibitorInhibitor0.9084
CYP450 2C19 inhibitorNon-inhibitor0.7252
CYP450 3A4 inhibitorNon-inhibitor0.8047
CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.5951
Ames testAMES toxic0.7423
CarcinogenicityNon-carcinogens0.8758
BiodegradationNot ready biodegradable1.0
Rat acute toxicity2.7935 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Strong inhibitor0.645
hERG inhibition (predictor II)Inhibitor0.7439
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-0000900000-70b5aacf411f642a898c
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-014i-2002900000-b4eff92c74f50ed0ed65
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-1103900000-997a4218a7e5c83d0d5c
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-001i-9005100000-0f750425f19da70b6c18
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0abc-2193100000-52e880ccbd510c9bf285
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-001i-9005000000-82abac636e03666efcb4
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-206.44287
predicted
DeepCCS 1.0 (2019)
[M+H]+209.01143
predicted
DeepCCS 1.0 (2019)
[M+Na]+216.83173
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Trypanosoma cruzi
Pharmacological action
Unknown
Actions
Inhibitor
General Function
Trypanothione-disulfide reductase activity
Specific Function
Trypanothione is the parasite analog of glutathione; this enzyme is the equivalent of glutathione reductase.
Gene Name
TPR
Uniprot ID
P28593
Uniprot Name
Trypanothione reductase
Molecular Weight
53867.475 Da
References
  1. Saravanamuthu A, Vickers TJ, Bond CS, Peterson MR, Hunter WN, Fairlamb AH: Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design. J Biol Chem. 2004 Jul 9;279(28):29493-500. Epub 2004 Apr 21. [Article]
  2. Hossain MU, Oany AR, Ahmad SA, Hasan MA, Khan MA, Siddikey MA: Identification of potential inhibitor and enzyme-inhibitor complex on trypanothione reductase to control Chagas disease. Comput Biol Chem. 2016 Dec;65:29-36. doi: 10.1016/j.compbiolchem.2016.10.002. Epub 2016 Oct 7. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52